miRNA 7641-2: A Potential Drug Target or Biomarker (G102465753)
miRNA 7641-2: A Potential Drug Target or Biomarker
MicroRNA 7641-2 (hsa-mir-7641-2) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a member of the miRNA family, which are small non-coding RNAs that play a critical role in post-transcriptional gene regulation. miRNAs have been shown to play a key role in the regulation of cellular processes such as cell growth, apoptosis, and metabolism.
The hsa-mir-7641-2 gene has been identified in various organisms, including humans. It is expressed in a variety of tissues, including the brain, heart, and kidneys. The function of hsa-mir-7641-2 is not well understood, but it is known to play a role in the regulation of cellular processes such as cell adhesion, migration, and angiogenesis.
One of the key features of hsa-mir-7641-2 is its ability to interact with other proteins. It has been shown to interact with various proteins, including the protein known as SMAD4. SMAD4 is a transcription factor that plays a critical role in the regulation of cellular processes such as cell growth, apoptosis, and metabolism. The interaction between hsa-mir-7641-2 and SMAD4 suggests that hsa-mir-7641-2 may be a potential drug target or biomarker for diseases that are characterized by the over-expression or under-expression of SMAD4.
Another potential function of hsa-mir-7641-2 is its role in the regulation of cellular apoptosis. Apoptosis is a natural process that is involved in the regulation of cellular life and death. It is characterized by the release of cellular organelles such as mitochondrial DNA and the cleavage of cellular bonds. Hsa-mir-7641-2 has been shown to play a role in the regulation of apoptosis in various organisms. For example, it has been shown to induce the apoptosis in cancer cells, while it has also been shown to protect against apoptosis in healthy cells.
In addition to its potential role in apoptosis, hsa-mir-7641-2 is also known to play a role in the regulation of cell adhesion. Cell adhesion is the process by which cells stick together to form tissues and organs. It is a critical process that is involved in the development and maintenance of tissues and organs. Hsa-mir-7641-2 has been shown to play a role in the regulation of cell adhesion in various organisms. For example, it has been shown to promote the stickiness of cancer cells to the surface of healthy cells, which may contribute to their ability to metastasize.
Another potential function of hsa-mir-7641-2 is its role in the regulation of cellular metabolism. Cellular metabolism is the process by which cells convert energy and nutrients into the components necessary for growth and maintenance. It is a critical process that is involved in the development and maintenance of tissues and organs. Hsa-mir-7641-2 has been shown to play a role in the regulation of cellular metabolism in various organisms. For example, it has been shown to control the levels of glucose in cells, which is important for maintaining cellular health.
In conclusion, hsa-mir-7641-2 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its ability to interact with other proteins, including the protein known as SMAD4, suggests that it may be involved in the regulation of cellular processes such as cell growth, apoptosis, and metabolism. Further research is needed to fully understand the role of hsa-mir-7641-2 in these processes and its potential as a drug target or biomarker.
Protein Name: MicroRNA 7641-2
The "MicroRNA 7641-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MicroRNA 7641-2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
Microtubule-Associated Protein | MICU1 | MICU2 | MICU3 | MID1 | MID1IP1 | MID1IP1-AS1 | MID2 | MIDEAS | MIDEAS-AS1 | MIDN | MIEF1 | MIEF2 | MIEN1 | MIER1 | MIER2 | MIER3 | MIF | MIF-AS1 | MIF4GD | MIGA1 | MIGA2 | MIIP | MILIP | MILR1 | MIMT1 | MINAR1 | MINAR2 | MINCR | MINDY1 | MINDY2 | MINDY2-DT | MINDY3 | MINDY4 | Minichromosome maintenance (MCM) 2-7 helicase complex | MINK1 | MINPP1 | MIOS | MIOX | MIP | MIPEP | MIPEPP3 | MIPOL1 | MIR1-1 | MIR1-1HG | MIR1-2 | MIR100 | MIR100HG | MIR101-1 | MIR101-2 | MIR10394 | MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229
